245 related articles for article (PubMed ID: 32443549)
1. Serum Exosomal miRNAs for Grading Hepatic Fibrosis Due to Schistosomiasis.
Cai P; Mu Y; Olveda RM; Ross AG; Olveda DU; McManus DP
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443549
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis.
Cai P; Mu Y; Olveda RM; Ross AG; Olveda DU; McManus DP
EBioMedicine; 2018 Nov; 37():334-343. PubMed ID: 30482723
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA dysregulation in schistosomiasis-induced hepatic fibrosis: a systematic review.
Nóbrega DND; Carvalho TL; do Ó KP; Lima RE; Farias ICC; Souza RDS; Pereira JB; Maranhão ACN; Lima VFDS; Melo ALTM; Silva TCG; Belmont TFM; Gomes ECS; Vasconcelos LRS
Expert Rev Mol Diagn; 2023 Mar; 23(3):257-265. PubMed ID: 36803616
[TBL] [Abstract][Full Text] [Related]
4. Autophagy in hepatic progenitor cells modulates exosomal miRNAs to inhibit liver fibrosis in schistosomiasis.
Yuan Y; Li J; Lu X; Chen M; Liang H; Chen XP; Long X; Zhang B; Gong S; Huang X; Zhao J; Chen Q
Front Med; 2024 Jun; 18(3):538-557. PubMed ID: 38769281
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNAs: Potential Novel Biomarkers for Hepatopathology Progression and Diagnosis of Schistosomiasis Japonica in Two Murine Models.
Cai P; Gobert GN; You H; Duke M; McManus DP
PLoS Negl Trop Dis; 2015; 9(7):e0003965. PubMed ID: 26230095
[TBL] [Abstract][Full Text] [Related]
6. Using Next-generation Sequencing to Identify Novel Exosomal miRNAs as Biomarkers for Significant Hepatic Fibrosis.
Wang Q; Hu Q; Ying Y; Lu C; Li W; Huang C; Xu W; Li Q; Qi X; Zhang X; Liu X; Du Z; Feng Y; Zhang Y; Li X; Ji Y; Zhang J; Wang J; Chen L; Huang Y
Discov Med; 2021; 31(164):147-159. PubMed ID: 35188889
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as Biomarkers of Hepatic Fibrosis in Schistosomiasis Japonica Patients in the Philippines.
Tabios IKB; Sato MO; Tantengco OAG; Fornillos RJC; Kirinoki M; Sato M; Rojo RD; Fontanilla IKC; Chigusa Y; Medina PMB; Kikuchi M; Leonardo LR
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010252
[TBL] [Abstract][Full Text] [Related]
8. A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III.
He X; Wang Y; Fan X; Lei N; Tian Y; Zhang D; Pan W
J Hepatol; 2020 Mar; 72(3):519-527. PubMed ID: 31738999
[TBL] [Abstract][Full Text] [Related]
9. Mmu-miR-92a-2-5p targets TLR2 to relieve Schistosoma japonicum-induced liver fibrosis.
Zhao Y; Dang Z; Chong S
Int Immunopharmacol; 2019 Apr; 69():126-135. PubMed ID: 30708193
[TBL] [Abstract][Full Text] [Related]
10. Evidence for an important role of host microRNAs in regulating hepatic fibrosis in humans infected with Schistosoma japonicum.
Cabantous S; Hou X; Louis L; He H; Mariani O; Sastre X; Daujat-Chavanieu M; Li Y; Dessein A
Int J Parasitol; 2017 Nov; 47(13):823-830. PubMed ID: 28739251
[TBL] [Abstract][Full Text] [Related]
11. MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6C
Liu L; Wang P; Wang YS; Zhang YN; Li C; Yang ZY; Liu ZH; Zhan TZ; Xu J; Xia CM
Front Immunol; 2021; 12():696069. PubMed ID: 34421906
[TBL] [Abstract][Full Text] [Related]
12. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29a-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting Roundabout homolog 1 in hepatic stellate cells.
Kong H; Song Q; Hu W; Guo S; Xiang D; Huang S; Xu X; He J; Pan L; Tao R; Yu H; Huang J
Parasit Vectors; 2023 Jun; 16(1):184. PubMed ID: 37280619
[TBL] [Abstract][Full Text] [Related]
14. Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy.
He X; Sai X; Chen C; Zhang Y; Xu X; Zhang D; Pan W
Parasit Vectors; 2013 Sep; 6():272. PubMed ID: 24330517
[TBL] [Abstract][Full Text] [Related]
15. Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis.
Zhang P; Wang BJ; Wang JZ; Xie XM; Tong QX
Curr Med Sci; 2020 Dec; 40(6):1121-1127. PubMed ID: 33428140
[TBL] [Abstract][Full Text] [Related]
16. Parasite-derived circulating microRNAs as biomarkers for the detection of human
Mu Y; Cai P; Olveda RM; Ross AG; Olveda DU; McManus DP
Parasitology; 2020 Jul; 147(8):889-896. PubMed ID: 31840631
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of serum exosomal microRNA in liver fibrosis.
Chang Y; Han JA; Kang SM; Jeong SW; Ryu T; Park HS; Yoo JJ; Lee SH; Kim SG; Kim YS; Kim HS; Jin SY; Ryu S; Jang JY
PLoS One; 2021; 16(9):e0255672. PubMed ID: 34506494
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection.
Cai P; Piao X; Liu S; Hou N; Wang H; Chen Q
PLoS One; 2013; 8(6):e67037. PubMed ID: 23825609
[TBL] [Abstract][Full Text] [Related]
19. [Roles of transforming growth factor - β1 and heat shock protein 47 in progression of
Yong-Hua Z; Chen X; Ying-Ying Y; Cong-Jin M; Pan-Pan D; Xue S; Yong-Liang X; Xiao-Lin F; Jun-Qi Y; Li-Juan S
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2019 Sep; 31(4):382-387. PubMed ID: 31612672
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-29b-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting COL1A1 and COL3A1.
Tao R; Fan XX; Yu HJ; Ai G; Zhang HY; Kong HY; Song QQ; Huang Y; Huang JQ; Ning Q
J Cell Biochem; 2018 Apr; 119(4):3199-3209. PubMed ID: 29091295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
